ThePolitibase
H.R. 5343IntroducedHEALTH

Ensuring Patient Access to Critical Breakthrough Products Act

Congressional oversight · Drug safety, medical device, and laboratory regulation · Health care costs and insurance
Sponsor
Rep. Moore, Blake D. [R-UT-1]
R · UT-1
Key facts
Introduced: Sep 15, 2025
Chamber: House
Cosponsors: 47
Congress: 119th
Latest action · Sep 17, 2025
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.

Timeline

  1. Sep 17, 2025
    Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.
  2. Sep 17, 2025
    Committee Consideration and Mark-up Session Held
  3. Sep 15, 2025
    Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. Sep 15, 2025
    Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  5. Sep 15, 2025
    Introduced in House
  6. Sep 15, 2025
    Introduced in House

Cosponsors (showing first 30 of 47)

In the News

View official record on Congress.gov →
Make your voice heard

Contact your representatives about this bill in under 2 minutes.

📬 Contact Your Reps →